Cargando…

Dual Bronchodilator in the Era of Triple Therapy

Pharmacological medications used for the treatment of COPD patients have increased significantly. Long-acting bronchodilators have been recognized as the mainstay of the treatment of stable COPD, while ICS are usually added in patients with COPD who experience exacerbations, despite bronchodilator t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papaioannou, Andriana I, Loukides, Stelios, Bakakos, Petros, Kosmas, Epameinondas N, Rovina, Nikoletta, Steiropoulos, Paschalis, Fouka, Evangellia, Hillas, Georgios, Patentalakis, Georgios, Kouvela, Marousa, Tzanakis, Nikos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604249/ https://www.ncbi.nlm.nih.gov/pubmed/33149567 http://dx.doi.org/10.2147/COPD.S273987

Ejemplares similares

IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community
por: Tzanakis, Nikolaos, et al.
Publicado: (2022)

Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions
por: Fouka, Evangelia, et al.
Publicado: (2022)

Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Sestrin 2 levels are associated with emphysematous phenotype of COPD
por: Angelakis, Leonidas, et al.
Publicado: (2022)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm
por: Tomos, Ioannis, et al.
Publicado: (2020)

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
por: Papaporfyriou, Anastasia, et al.
Publicado: (2023)

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023)

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

Severe Eosinophilic Asthma
por: Bakakos, Agamemnon, et al.
Publicado: (2019)

Depression Levels Influence the Rate of Asthma Exacerbations in Females
por: Anastasia, Papaporfyriou, et al.
Publicado: (2021)

Unraveling the Relationship of Asthma and COVID-19
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?
por: Tsilogianni, Zoe, et al.
Publicado: (2020)

Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
por: Papaioannou, Andriana I, et al.
Publicado: (2011)

Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016)

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?
por: Voulgareli, Ilektra, et al.
Publicado: (2023)

Implication of IL-18 in chronic inflammation of severe refractory asthma
por: Rovina, Nikoletta, et al.
Publicado: (2015)

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients
por: Hillas, Georgios, et al.
Publicado: (2010)

An Observational Study Assessing Changes in Health and Functional Status in Patients with Chronic Obstructive Pulmonary Disease (COPD) During Therapy with Spiolto(®) Respimat(®) in Everyday Clinical Practice: The Greek ELLACTO Study
por: Kosmas, Epaminondas, et al.
Publicado: (2021)

Revisiting IL-13 blockade: can we reach the wonderland the inhaled way?
por: Papaioannou, Andriana I., et al.
Publicado: (2018)

Modified SCOPE (mSCOPE) Score as a Tool to Predict Mortality in COVID-19 Critically Ill Patients
por: Zanelli, Stavroula, et al.
Publicado: (2023)

C-Reactive Protein as a Predictor of Survival and Length of Hospital Stay in Community-Acquired Pneumonia
por: Travlos, Apostolos, et al.
Publicado: (2022)

A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
por: Bakakos, Agamemnon, et al.
Publicado: (2023)

Acute exacerbation of COPD: is it the “stroke of the lungs”?
por: Hillas, Georgios, et al.
Publicado: (2016)

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study
por: Karampitsakos, Theodoros, et al.
Publicado: (2020)

Asthma with Fixed Airflow Obstruction: From Fixed to Personalized Approach
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Managing comorbidities in COPD
por: Hillas, Georgios, et al.
Publicado: (2015)

The Real Impact of Age on Mortality in Critically Ill COVID-19 Patients
por: Bakakos, Agamemnon, et al.
Publicado: (2023)

COVID-19 Advanced Care
por: Fouka, Evangelia, et al.
Publicado: (2021)

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
por: Striz, Ilja, et al.
Publicado: (2023)

Validation of NoSAS score for the screening of obstructive sleep apnea
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g4pjg8pmgcbb8qunalbbaphkg4